Kind Indication News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kind Indication. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kind Indication Today - Breaking & Trending Today

KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomnia Symptoms

Published: March 29, 2024

A phase 2 trial found KP1077 provides clinically meaningful benefits for idiopathic hypersomnia.

Source: hcplive.com

Related Topics:

United StatesChristopher DrakeHenry Ford Health Christopher DrakeAmerican Academy Of Sleep MedicineDrug AdministrationUs Drug Enforcement AgencyHenry Ford HealthZevra TherapeuticsAmerican AcademyOrphan Drug DesignationEnforcement AgencyEpworth Sleepiness ScaleIdiopathic Hypersomnia Severity ScaleSleep Inertia Visual Analog ScaleEpworth SleepinessBrain Fog Severity ScaleTherapeutics Announces Top Line DataGlobal NewsKind IndicationChronic Sleep DisorderAccessed MarchIdiopathic HypersomniaSleep ProblemsExcessive Sleepiness